Items where authors include "Morgan, R."

Article

Smith, D.A., Novakovic, L., Clatworthy, J. et al. (29 more authors) (2023) Book reviews. Modern Believing, 64 (2). pp. 163-226. ISSN 1353-1425

Poole, A.P., Finnis, M.E., Anstey, J. et al. (106 more authors) (2022) The effect of a liberal approach to glucose control in critically ill patients with type 2 diabetes: a multicenter, parallel-group, open-label randomized clinical trial. American Journal of Respiratory and Critical Care Medicine, 206 (7). pp. 874-882. ISSN 1073-449X

Padam, K.S.R., Morgan, R., Hunter, K. orcid.org/0000-0002-7873-0877 et al. (3 more authors) (2022) Identification of HOX signatures contributing to oral cancer phenotype. Scientific Reports, 12 (1). 10123.

Morgan, R., Hunter, K. orcid.org/0000-0002-7873-0877 and Pandha, H.S. (2022) Downstream of the HOX genes: explaining conflicting tumour suppressor and oncogenic functions in cancer. International Journal of Cancer, 150 (12). pp. 1919-1932. ISSN 0020-7136

Shenoy, U.S., Morgan, R., Hunter, K. et al. (2 more authors) (2022) Integrated computational analysis reveals HOX genes cluster as oncogenic drivers in head and neck squamous cell carcinoma. Scientific Reports, 12 (1). p. 7952.

Durojaiye, O.C., Morgan, R., Chelaghma, N. et al. (1 more author) (2021) Clinical predictors of outcome in patients with infective endocarditis receiving outpatient parenteral antibiotic therapy (OPAT). Journal of Infection, 83 (6). pp. 644-649. ISSN 0163-4453

Durojaiye, O.C., Morgan, R., Chelaghma, N. et al. (5 more authors) (2021) External validity and clinical usefulness of a risk prediction model for 30 day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy. Journal of Antimicrobial Chemotherapy, 76 (8). pp. 2204-2212. ISSN 0305-7453

Primon, M., Hunter, K.D. orcid.org/0000-0002-7873-0877, Pandha, H.S. et al. (1 more author) (2019) Kinase regulation of HOX transcription factors. Cancers, 11 (4). 508. ISSN 2072-6694

Platais, C., Radhakrishnan, R., Ebensberger, S.N. et al. (3 more authors) (2018) Targeting HOX-PBX interactions causes death in oral potentially malignant and squamous carcinoma cells but not normal oral keratinocytes. BMC Cancer, 18. 723. ISSN 1471-2407

Morgan, R., El-Tanani, M., Hunter, K.D. orcid.org/0000-0002-7873-0877 et al. (2 more authors) (2017) Targeting HOX/PBX dimers in cancer. Oncotarget, 8 (19). pp. 32322-32331.

Darda, L., Hakami, F., Morgan, R. et al. (3 more authors) (2015) The Role of HOXB9 and miR-196a in Head and Neck Squamous Cell Carcinoma. PLoS One, 10 (4). e0122285 . - .